Ypsomed Holding AG operates in the Surgical and medical instruments sector. Ypsomed Holding AG is a Switzerland-based company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. Its range of products includes simple disposable pens, variable dosing pens, pens with electronic display, highly complex injectors, auto-injector devices and needle-free devices. The Company's products can be used for various therapies and applications, such as blood glucose monitoring, insulin therapy, renal anemia therapy, growth hormone therapy, infertility treatment and osteoporosis. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe. In our complete report available for purchase the company is compared to: Coltene Holding AG, Lifewatch AG and IVF Hartmann Holding AG.